STING1 and diabetic cardiomyopathy: In 2022, Lu et al. demonstrated that the cardiomyocyte-specific overexpression of Meteorin-like hormone (METRNL) ameliorated diabetic cardiomyopathy by simultaneously activating autophagy and inhibiting cGAS/STING signaling.